Programs & Partnerships
Flu Lab's portfolio of grants and investments collectively work to enhance and expand the influenza ecosystem, and stimulate and accelerate research and translation of discoveries into applied technologies and medical countermeasures.
Flu Lab Activities:
Flu Lab supports the Sabin Vaccine Institute and its efforts to draw attention to the pressing need for a universal influenza vaccine and bring new perspectives to invigorate influenza research. We have joined their Influenzer Initiative which seeks expertise from different disciplines to develop a universal influenza vaccine that provides longer-lasting immunity against multiple influenza strains.
Flu Lab, in collaboration with the Bill & Melinda Gates Foundation, launched the 2018 Grand Challenge for Universal Influenza Vaccine Development, offering USD $12 million in seed money for “game-changing” influenza vaccines proposals. The Grand Challenge will fund individual pilot awards of up to USD $2 million over two years.
Flu Lab is working with a variety of other funders on issues relevant to our mission, serving as launch points for our grantmaking.
Flu Lab is a member of the Global Funders Consortium for Universal Influenza Vaccine Development whose goal is to accelerate the development and availability of broadly protective influenza vaccines, thereby reducing the global burden and risk from seasonal and pandemic influenza.
Latest News: Sabin Vaccine Institute and The Aspen Institute Release Report Calling for Bold, New, and Coordinated Commitments to Making Universal Influenza Vaccines a Reality
Flu Lab is a member of the Pandemics Collective, a community of practice, representing philanthropic leadership in technology and global health, oriented to pandemic prevention, detection, and rapid response.